Tamir Biotechnology, Inc. (ACEL) Reports Q1 Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Tamir Biotechnology, Inc. (NYSE: ACEL) | Delayed: 13.42 +1.56 (13.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.86 | 52 Week High | $0.08 | |||
| Open | $12.85 | 52 Week Low | $0.00 | |||
| Day High | $13.79 | P/E | N/A | |||
| Day Low | $12.20 | EPS | $0.00 | |||
| Volume | 1,888,668 | |||||
